Market Cap$161.01B
P/E44.55x
PEG Ratio1.39
Div yield0.49%
Beta0.79
DHR Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)5.42%
Price vs S&P 500 (4W)7.44%
PEG Ratio1.39
VGM Score50.99
P/E Ratio (Annual)44.55x
Indicated Dividend Yield (Annual)0.49%
DHR Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $1.84 | $1.94 | +5.28%(+$0.10) | |
| Q1 2026 | $1.94 | $2.06 | +6.45%(+$0.12) | |
| Q4 2025 | $2.19 | $2.23 | +1.99%(+$0.04) | |
| Q3 2025 | $1.72 | $1.89 | +9.78%(+$0.17) | |
| Q2 2025 | $1.64 | $1.80 | +9.49%(+$0.16) |
DHR Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.27
4.19
4.22
4.22
Industry Peers — Industrial Instruments(16)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
DHRDanaher Corporation | D | C | B | 6.4x | 2.0% | 58.6% | 20.4% | $229.04 |
| AMEAmetek, Inc. | D | C | B | 7.2x | 10.3% | 36.9% | 25.6% | $248.17 |
| KEYSKeysight Technologies, Inc. | D | B | B | 8.6x | 5.0% | 64.7% | 20.3% | $331.21 |
| ROPRoper Technologies, Inc. Common Stock | C | B | B | 4.6x | 14.5% | 69.5% | 28.0% | $382.71 |
| FTVFortive Corporation | C | D | B | 4.0x | -2.1% | 63.2% | 18.2% | $57.79 |
| MKSIMKS Inc. Common Stock | C | B | C | 3.3x | 11.0% | 47.0% | 15.4% | $214.83 |
| CGNXCognex Corp | D | C | C | 8.3x | 4.2% | 68.9% | 21.8% | $53.99 |
| RALRalliant Corporation | C | C | B | 3.4x | — | 50.9% | -53.3% | $66.55 |
| STSensata Technologies Holding plc | B | D | B | 1.6x | 4.0% | 29.5% | 7.6% | $40.58 |
| MLABMesa Laboratories Inc | C | D | A | 2.7x | 13.2% | 64.2% | 9.0% | $122.48 |
| SENSSenseonics Holdings, Inc. Common Stock | D | A | B | 8.5x | 48.1% | 54.9% | -223.2% | $7.77 |
About Danaher Corporation
Danaher manufactures scientific instruments and consumables for the life sciences and diagnostics industries. The company has shaped its portfolio through strategic acquisitions and divestitures, most notably the late 2023 separation of its environmental and applied solutions group, Veralto, to focus entirely on life sciences and diagnostics.